本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的，不可用于人类或动物的临床诊断或者治疗，非药用，非食用。
利妥昔单抗
英文名：Rituximab
Cas号：
Cas号：
检测信息查询
| 别 名 | 美罗华;美罗华(利妥昔单抗) |
| Cas号 | |
| M D L | |
| 分子式 | |
| 分子量 | |
| 产品参数 | Description
Rituximab is an anti-CD20 chimeric monoclonal antibody used to treat certain autoimmune diseases and types of cancer. Molecular Weight 144544.44 Shipping Shipping with dry ice. Storage Please store the product under the recommended conditions in the Certificate of Analysis. References [1]. Kamburova EG, et al. In vitro effects of rituximab on the proliferation, activation and differentiation of human B cells. Am J Transplant. 2012 Feb;12(2):341-50. [2]. Manches O, et al. In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas. Blood. 2003 Feb 1;101(3):949-54. [3]. Byrd JC, et al. The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction. Blood. 2002 Feb 1;99(3):1038-43. |
| 性状 | Rituximab是用于治疗某些自身免疫疾病和癌症类型的抗CD20嵌合单克隆抗体。 |
| 贮存 |
沪公网安备 31012002003054号